Mavenclad (cladribine)

£2,253.62£13,208.31

Mavenclad (cladribine) is a medication used for the treatment of relapsing forms of multiple sclerosis (MS).

For this product the estimated delivery time is usually between 5 and 10 working days.

DISEASE INDICATIONS

Multiple Sclerosis

MANUFACTURER

Merck Serono Europe Limited

USAGE

Oral

MEDICINE APPROVED BY

  • European Medical Agency (EMA)

  • Food and Drug Administration (FDA)

  • Health Canada

  • Therapeutic Goods Administration (TGA)

  • Medsafe (NZ)

    PATIENTS HELPED

    • Over 1.2 million patients reached

    • More than 11,000 patients helped

    • 100% successful deliveries to 88 countries

    WE CAN HELP WITH YOUR IMPORT DOCUMENTS

    We are experts in import regulations.

This content has been reviewed by a Medical Doctor.
Shopping Cart